← All stories
Markets
Celadon Pharmaceuticals (LSE:CEL): Can Home-Grown Supply Reshape UK Medical Cannabis?
Highlights Domestic cultivation reduces reliance on imported medical cannabis Progress hinges on licensing, quality standards and clinical acceptance London small-cap conditions remain a constraint on the sector Celadon Pharmaceuticals (LSE…
Covered by 1 outlet
All coverage · 1 article